<code id='14390CEBE4'></code><style id='14390CEBE4'></style>
    • <acronym id='14390CEBE4'></acronym>
      <center id='14390CEBE4'><center id='14390CEBE4'><tfoot id='14390CEBE4'></tfoot></center><abbr id='14390CEBE4'><dir id='14390CEBE4'><tfoot id='14390CEBE4'></tfoot><noframes id='14390CEBE4'>

    • <optgroup id='14390CEBE4'><strike id='14390CEBE4'><sup id='14390CEBE4'></sup></strike><code id='14390CEBE4'></code></optgroup>
        1. <b id='14390CEBE4'><label id='14390CEBE4'><select id='14390CEBE4'><dt id='14390CEBE4'><span id='14390CEBE4'></span></dt></select></label></b><u id='14390CEBE4'></u>
          <i id='14390CEBE4'><strike id='14390CEBE4'><tt id='14390CEBE4'><pre id='14390CEBE4'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:6637
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          White House announces new plan to address the growing threat of xylazine in overdose crisis
          White House announces new plan to address the growing threat of xylazine in overdose crisis

          RahulGupta,theBidenAdministration'sdrugczar,saidthegovernmentisusing"everyleverwehavetoprotectpublic

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          A new ‘biological computer' targets cancer while sparing healthy cells

          AdobeTheholygrailofcancerdrugtargetsisakintoaunicornhorn:amarkerthatonlycancercellshave,clearlydisti